# Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

> **NCT03956225** · NA · COMPLETED · sponsor: **Alcon Research** · enrollment: 299 (actual)

## Conditions studied

- Meibomian Gland Dysfunction
- Evaporative Dry Eye Disease

## Interventions

- **DEVICE:** Systane iLux® Dry Eye System
- **DEVICE:** LipiFlow® Thermal Pulsation System

## Key facts

- **NCT ID:** NCT03956225
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-25
- **Primary completion:** 2020-10-24
- **Final completion:** 2020-10-24
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2021-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03956225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03956225, "Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03956225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*